• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

The consequences of translational and rotational entropy lost by small molecules on binding to proteins.

作者信息

Murray Christopher W, Verdonk Marcel L

机构信息

Astex Technology Ltd, 250 Cambridge Science Park, Milton Road, Cambridge, CB4 0WE, UK.

出版信息

J Comput Aided Mol Des. 2002 Oct;16(10):741-53. doi: 10.1023/a:1022446720849.

DOI:10.1023/a:1022446720849
PMID:12650591
Abstract

When a small molecule binds to a protein, it loses a significant amount of rigid body translational and rotational entropy. Estimates of the associated energy barrier vary widely in the literature yet accurate estimates are important in the interpretation of results from fragment-based drug discovery techniques. This paper describes an analysis that allows the estimation of the rigid body entropy barrier from the increase in binding affinities that results when two fragments of known affinity and known binding mode are joined together. The paper reviews the relatively rare number of examples where good quality data is available. From the analysis of this data, we estimate that the barrier to binding, due to the loss of rigid-body entropy, is 15-20 kJ/mol, i.e. around 3 orders of magnitude in affinity at 298 K. This large barrier explains why it is comparatively rare to observe multiple fragments binding to non-overlapping adjacent sites in enzymes. The barrier is also consistent with medicinal chemistry experience where small changes in the critical binding regions of ligands are often poorly tolerated by enzymes.

摘要

相似文献

1
The consequences of translational and rotational entropy lost by small molecules on binding to proteins.
J Comput Aided Mol Des. 2002 Oct;16(10):741-53. doi: 10.1023/a:1022446720849.
2
Efficient Approximation of Ligand Rotational and Translational Entropy Changes upon Binding for Use in MM-PBSA Calculations.用于MM-PBSA计算的配体结合时旋转和平动熵变的高效近似
J Chem Inf Model. 2017 Feb 27;57(2):170-189. doi: 10.1021/acs.jcim.6b00373. Epub 2017 Jan 20.
3
Loss of translational entropy in molecular associations.分子缔合中平移熵的损失。
Proteins. 2004 Jan 1;54(1):104-15. doi: 10.1002/prot.10472.
4
General Theory of Fragment Linking in Molecular Design: Why Fragment Linking Rarely Succeeds and How to Improve Outcomes.分子设计中的片段连接一般理论:为何片段连接很少成功,以及如何改善结果。
J Chem Theory Comput. 2021 Jan 12;17(1):450-462. doi: 10.1021/acs.jctc.0c01004. Epub 2020 Dec 29.
5
Calculation of cyclodextrin binding affinities: energy, entropy, and implications for drug design.环糊精结合亲和力的计算:能量、熵及其对药物设计的影响。
Biophys J. 2004 Nov;87(5):3035-49. doi: 10.1529/biophysj.104.049494. Epub 2004 Aug 31.
6
Direct estimation of entropy loss due to reduced translational and rotational motions upon molecular binding.分子结合时平移和旋转运动减少导致的熵损失的直接估计。
Biopolymers. 2005 Dec 5;79(5):277-85. doi: 10.1002/bip.20344.
7
Flexibility and conformational entropy in protein-protein binding.蛋白质-蛋白质结合中的柔韧性与构象熵
Structure. 2006 Apr;14(4):683-93. doi: 10.1016/j.str.2006.01.014.
8
Calculation of absolute protein-ligand binding affinity using path and endpoint approaches.使用路径和端点方法计算绝对蛋白质-配体结合亲和力。
Biophys J. 2006 Feb 1;90(3):864-77. doi: 10.1529/biophysj.105.071589. Epub 2005 Nov 11.
9
Single water entropy: hydrophobic crossover and application to drug binding.单水熵:疏水交叉及其在药物结合中的应用
J Phys Chem B. 2014 Sep 11;118(36):10553-64. doi: 10.1021/jp502852f. Epub 2014 Aug 26.
10
Entropy loss in long-distance DNA looping.远距离DNA环化中的熵损失
Biophys J. 2003 Jul;85(1):167-73. doi: 10.1016/S0006-3495(03)74463-4.

引用本文的文献

1
Deconstruction of Dual-Site Tankyrase Inhibitors Provides Insights into Binding Energetics and Suggests Critical Hotspots for Ligand Optimization.双位点端锚聚合酶抑制剂的解构为结合能提供了见解,并为配体优化指明了关键热点。
J Med Chem. 2025 Apr 10;68(7):7263-7279. doi: 10.1021/acs.jmedchem.4c02845. Epub 2025 Mar 25.
2
Thermal Titration Molecular Dynamics: The Revenge of the Fragments.热滴定分子动力学:片段的反击
J Chem Inf Model. 2025 Feb 10;65(3):1492-1513. doi: 10.1021/acs.jcim.4c01681. Epub 2025 Jan 21.
3
An artificial intelligence accelerated virtual screening platform for drug discovery.

本文引用的文献

1
On the attribution and additivity of binding energies.关于结合能的归因和可加性。
Proc Natl Acad Sci U S A. 1981 Jul;78(7):4046-50. doi: 10.1073/pnas.78.7.4046.
2
High-throughput crystallography for lead discovery in drug design.用于药物设计中先导化合物发现的高通量晶体学
Nat Rev Drug Discov. 2002 Jan;1(1):45-54. doi: 10.1038/nrd706.
3
Molecular complexity and its impact on the probability of finding leads for drug discovery.分子复杂性及其对药物发现中寻找先导化合物概率的影响。
人工智能加速药物发现的虚拟筛选平台。
Nat Commun. 2024 Sep 5;15(1):7761. doi: 10.1038/s41467-024-52061-7.
4
The Area Law of Molecular Entropy: Moving beyond Harmonic Approximation.分子熵的面积定律:超越简谐近似
Entropy (Basel). 2024 Aug 14;26(8):688. doi: 10.3390/e26080688.
5
Linking ATP and allosteric sites to achieve superadditive binding with bivalent EGFR kinase inhibitors.将ATP与变构位点相连以实现与二价表皮生长因子受体激酶抑制剂的超加成结合。
Commun Chem. 2024 Feb 20;7(1):38. doi: 10.1038/s42004-024-01108-3.
6
Linking ATP and allosteric sites to achieve superadditive binding with bivalent EGFR kinase inhibitors.连接ATP和变构位点以实现与二价表皮生长因子受体激酶抑制剂的超加成结合。
Res Sq. 2023 Sep 13:rs.3.rs-3286949. doi: 10.21203/rs.3.rs-3286949/v1.
7
Fragment-Based Approaches to Identify RNA Binders.基于片段的方法鉴定 RNA 结合物。
J Med Chem. 2023 May 25;66(10):6523-6541. doi: 10.1021/acs.jmedchem.3c00034. Epub 2023 May 15.
8
Forces Driving a Magic Bullet to Its Target: Revisiting the Role of Thermodynamics in Drug Design, Development, and Optimization.推动神奇子弹命中靶点的力量:重新审视热力学在药物设计、开发和优化中的作用
Life (Basel). 2022 Sep 15;12(9):1438. doi: 10.3390/life12091438.
9
Affinity of disordered protein complexes is modulated by entropy-energy reinforcement.无序蛋白质复合物的亲和力受熵-能强化的调节。
Proc Natl Acad Sci U S A. 2022 Jun 28;119(26):e2120456119. doi: 10.1073/pnas.2120456119. Epub 2022 Jun 21.
10
Structural and ITC Characterization of Peptide-Protein Binding: Thermodynamic Consequences of Cyclization Constraints, a Case Study on Vascular Endothelial Growth Factor Ligands.肽-蛋白结合的结构和 ITC 特性:环化限制的热力学后果,以血管内皮生长因子配体为例。
Chemistry. 2022 Aug 26;28(48):e202200465. doi: 10.1002/chem.202200465. Epub 2022 Jul 7.
J Chem Inf Comput Sci. 2001 May-Jun;41(3):856-64. doi: 10.1021/ci000403i.
4
Bivalent inhibition of human beta-tryptase.人β-胰蛋白酶的双价抑制作用
Chem Biol. 2001 Apr;8(4):313-27. doi: 10.1016/s1074-5521(01)00011-4.
5
Dibasic inhibitors of human mast cell tryptase. Part 1: synthesis and optimization of a novel class of inhibitors.人肥大细胞类胰蛋白酶的二元抑制剂。第1部分:一类新型抑制剂的合成与优化。
Bioorg Med Chem Lett. 2000 Oct 16;10(20):2357-60. doi: 10.1016/s0960-894x(00)00484-4.
6
Identification of novel inhibitors of urokinase via NMR-based screening.通过基于核磁共振的筛选鉴定新型尿激酶抑制剂
J Med Chem. 2000 Oct 19;43(21):3862-6. doi: 10.1021/jm0002228.
7
Discovering novel ligands for macromolecules using X-ray crystallographic screening.利用X射线晶体学筛选发现大分子的新型配体。
Nat Biotechnol. 2000 Oct;18(10):1105-8. doi: 10.1038/80319.
8
Site-directed ligand discovery.定点配体发现
Proc Natl Acad Sci U S A. 2000 Aug 15;97(17):9367-72. doi: 10.1073/pnas.97.17.9367.
9
Isn't combinatorial chemistry just chemistry?组合化学不就是化学吗?
Drug Discov Today. 2000 Aug;5(8):307-308. doi: 10.1016/s1359-6446(00)01476-8.
10
Novel inhibitors of DNA gyrase: 3D structure based biased needle screening, hit validation by biophysical methods, and 3D guided optimization. A promising alternative to random screening.
J Med Chem. 2000 Jul 13;43(14):2664-74. doi: 10.1021/jm000017s.